Advanced Search
Contact | Corporate | Help

Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial

Sponsors:
  • Johns Hopkins University
  • Genentech
Phases:
  • Phase I
  • Phase II
IndicationsAcronym:
  • Choroidal Neovascularization
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Ranibizumab
  • Drug: Ranibizumab
Enrollment:
10

Additional information about NCT00363168.


SourceSolution © 2008-2012